CVS Health Expands Testing Capabilities Amid Rise in COVID-19 Cases; Adds 44 Additional New Drive-Thru Test Sites in Texas (2024)

Market Closed - Nyse Other stock markets 16:00:02 2024-05-20 EDT			5-day change	1st Jan Change
57.4 ^USD	-0.49%		+1.65%	-27.30%

05-16	CVS Health Retail Division Launches Snacks Brand Well Market	MT
05-14	Transcript : CVS Health Corporation Presents at Bank of America Health Care Conference 2024, May-14-2024 07:20 AM

June 25, 2020 at 08:00 am

Latest news about CVS Health Corporation

CVS Health Retail Division Launches Snacks Brand Well Market	05-16	MT
Transcript : CVS Health Corporation Presents at Bank of America Health Care Conference 2024, May-14-2024 07:20 AM	05-14
Argus Research Adjusts Price Target on CVS Health to $80 From $100	05-08	MT
Mickey Mouse on Wall Street	05-08
ANALYST RECOMMENDATIONS : Walt Disney, Tractor Supply Company, KKR, Occidental Petroleum...	05-08
CVS Health Files Prospectus Supplement for Notes Sale	05-07	MT
FOMO is Back	05-07
ANALYST RECOMMENDATIONS : Nvidia, The Home Depot, Lowe's, Rollins...	05-07
Wells Fargo Adjusts CVS Health's Price Target to $60 From $76	05-07	MT
TD Cowen Downgrades CVS Health to Hold From Buy, Adjusts Price Target to $59 From $99	05-07	MT
Ameriprise Downgrades CVS Health to Hold From Buy	05-06	MT
Aetna will cover fertility treatments for LGBTQ people under court settlement	05-03	RE
ARC Independent Research Adjusts Price Target on CVS Health to $65 From $80	05-03	MT
Wall Street rises thanks to good and bad economic news	05-03
North American Morning Briefing : Apple, Amgen -2-	05-03	DJ
ANALYST RECOMMENDATIONS : Alphabet, Amgen, Starbucks, PayPal, Moderna...	05-03
HSBC Downgrades CVS Health to Hold From Buy, Adjusts Price Target to $62 From $91	05-03	MT
Cvs Health Insider Bought Shares Worth $500,294, According to a Recent SEC Filing	05-02	MT
Deutsche Bank Adjusts Price Target on CVS Health to $64 From $77	05-02	MT
Raymond James Adjusts Price Target on CVS Health to $65 From $85	05-02	MT
Wolfe Adjusts Price Target on CVS Health to $70 From $88	05-02	MT
Morgan Stanley Adjusts Price Target on CVS Health to $65 From $85	05-02	MT
Jefferies Adjusts Price Target on CVS Health to $72 From $95	05-02	MT
Barclays Adjusts Price Target on CVS Health to $63 From $78	05-02	MT
Bernstein Adjusts Price Target on CVS Health to $62 From $93	05-02	MT

Chart CVS Health Corporation

Duration

Period

More charts

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows:- medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursem*nt management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.;- retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®);- medical benefits management (25.8%);- other (0.1%).

Sector

Calendar

2024-05-29 - Bernstein Strategic Decisions Conference - Fireside Chat

Related indices

More about the company

Income Statement Evolution

More financial data

Ratings for CVS Health Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

57.4USD

Average target price

71.37USD

Spread / Average Target

+24.34%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

	1st Jan change	Capi.
CVS HEALTH CORPORATION	-27.30%	72.06B
HCA HEALTHCARE, INC.	+20.09%	85.14B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+2.89%	27.07B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-9.00%	17.43B
	-2.03%	16.98B
QUEST DIAGNOSTICS INCORPORATED	+4.56%	16.02B
NATERA, INC.	+69.72%	13.06B
FRESENIUS MEDICAL CARE AG	+3.87%	12.9B
TENET HEALTHCARE CORPORATION	+73.30%	12.79B
DAVITA INC.	+34.53%	12.36B

Stock Market
Equities
CVS Stock
News CVS Health Corporation
CVS Health Expands Testing Capabilities Amid Rise in COVID-19 Cases; Adds 44 Additional New Drive-Thru Test Sites in Texas

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities. BENEFIT NOW

"); InvestingChannelQueue.push(function() { aICTags["oop"] = ic_page.defineOutOfPageTag("4Traders/quotepages","zppOOP"); aICTags["oop"].setKval({"adslot":"d_OOP_1"}); aICTags["oop"].render(); }); while (aAdsQueue.length) { (aAdsQueue.shift())(); } InvestingChannelQueue.push(function() { displayViewableAds('InvestingChannel'); $( window ).scroll(function() { displayViewableAds('InvestingChannel'); }); }); }gaEvent('adspv', 'InvestingChannel', 'US');googletag.cmd.push(function() { googletag.pubads().setTargeting('Edition', 'en_CA');googletag.pubads().setTargeting('UserType', 'free');googletag.pubads().setTargeting('Content', 'equities');googletag.pubads().setTargeting('codezb', '12230');googletag.enableServices();googletag.pubads().collapseEmptyDivs();try{googletag.pubads().getSlots().forEach(function(slot){if(slot.getSlotElementId().startsWith('zpp')){;}else{googletag.pubads().refresh([slot],{changeCorrelator: false});}})}catch(error){console.error(error)}});$(document).ready(function() { $( document).on('zbv_visible',function () {startAdsService();}); if (document[zbv_hidden]===false) { startAdsService(); } });